SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Human cytomegalovirus shedding and T-cell immune responses in HCMV-seropositive women during pregnancy and postpartum: prevalence, natural history, and risk factors

Sapuan, S; Tan, NK; Carrington, D; Greening, V; Jones, CE; Khalil, A; Pope, CF; Strang, BL; White, S; Heath, PT (2026) Human cytomegalovirus shedding and T-cell immune responses in HCMV-seropositive women during pregnancy and postpartum: prevalence, natural history, and risk factors. Clinical Infectious Diseases. ciag076. ISSN 1058-4838 https://doi.org/10.1093/cid/ciag076
SGUL Authors: Heath, Paul Trafford

[img] Microsoft Word (.docx) Accepted Version
Available under License Creative Commons Attribution.

Download (205kB)

Abstract

Background Human cytomegalovirus (HCMV) during pregnancy and poor immune control of HCMV are associated with adverse outcomes. Limited data exist on the prevalence, natural history, and risk factors of HCMV shedding and T-cell immune responses during pregnancy and postpartum in HCMV-seropositive women. Methods Samples from 160 HCMV-seropositive women were collected at three timepoints during pregnancy and once postpartum. Shedding was determined by detecting HCMV DNA in saliva, urine, and vaginal secretions by quantitative PCR. HCMV-specific T-cell immune responses were determined by detecting interferon-gamma released in blood by QuantiFERON-CMV and T-SPOT.CMV assays. Information on demographics and contact with children’s bodily fluids was collected. Results The prevalence of HCMV shedding in HCMV-seropositive women in any bodily fluids was 18.8% [95% CI: 13.0-25.7%] during pregnancy and 21.3% [95% CI: 15.2-28.4%] including postpartum. Ethnicity [OR 0.2, 95% CI: 0.05-0.95, p=.043] and gravidity [OR 0.2, 95% CI: 0.05-0.94, p=.042] were associated with detection of shedding. Shedding quantity was associated with contact with children’s saliva [Incidence rate ratio 1.98, 95% CI: 1.69-2.33, p<.001]. The prevalence of T-cell immune responses was ≤75% and almost 100% using QuantiFERON-CMV and T-SPOT.CMV, respectively. T-cell immune responses did not correlate with shedding. Conclusions Around 1 in 5 HCMV-seropositive women shed HCMV during pregnancy and postpartum. Ethnicity and gravidity are associated with shedding, but not T-cell immune responses, and the quantity of shedding is associated with contact with saliva. Further studies investigating HCMV shedding, immune responses and their risk factors in women during pregnancy and postpartum are warranted.

Item Type: Article
Additional Information: © The Author(s) 2026. Published by Oxford University Press on behalf of Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Keywords: T-cell, cytomegalovirus, postpartum, pregnancy, seropositive, shedding
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: Clinical Infectious Diseases
ISSN: 1058-4838
Language: en
Media of Output: Print-Electronic
Related URLs:
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
58414Merck Sharpe & DohmeUNSPECIFIED
PubMed ID: 41697938
Dates:
Date Event
2026-02-16 Published Online
2026-02-02 Accepted
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/118393
Publisher's version: https://doi.org/10.1093/cid/ciag076

Actions (login required)

Edit Item Edit Item